Arcturus Therapeutics Holdings (ARCT) Long-Term Investments (2018 - 2022)
Arcturus Therapeutics Holdings (ARCT) posted Long-Term Investments of $131000.0 for Q1 2022, down 74.56% on a QoQ basis from $515000.0 in Q4 2021, and down 89.5% year-over-year from $1.2 million in Q1 2021.
Arcturus Therapeutics Holdings (ARCT) Long-Term Investments (2018 - 2022) Analysis & Trends
Arcturus Therapeutics Holdings' Long-Term Investments history runs 5 years deep, the most recent figure standing at $131000.0 for Q1 2022.
- Quarterly Long-Term Investments fell 89.5% year-over-year to $131000.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $131000.0 (down 89.5% YoY) and the FY2021 annual result came in at $515000.0, changed N/A from the prior year.
- Long-Term Investments was $131000.0 for Q1 2022 at Arcturus Therapeutics Holdings, down from $515000.0 in the prior quarter.
- Across five years, Long-Term Investments topped out at $1.2 million in Q1 2021 and bottomed at $100000.0 in Q1 2020.
- A 5-year average of $493111.1 and a median of $303000.0 in 2019 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2021 — Long-Term Investments jumped 1148.0% — and 2022, when it tumbled 89.5%.
- Arcturus Therapeutics Holdings' Long-Term Investments stood at $288000.0 in 2018, then decreased by 8.68% to $263000.0 in 2019, then plunged by 61.98% to $100000.0 in 2020, then surged by 415.0% to $515000.0 in 2021, then tumbled by 74.56% to $131000.0 in 2022.
- Business Quant data shows ARCT's Long-Term Investments at $131000.0 in Q1 2022, $515000.0 in Q4 2021, and $670000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arcturus Therapeutics Holdings | 164.57 Mn | -46.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 131,000.00 |
| Dec 31, 2021 | 515,000.00 |
| Sep 30, 2021 | 670,000.00 |
| Jun 30, 2021 | 920,000.00 |
| Mar 31, 2021 | 1.25 Mn |
| Mar 31, 2020 | 100,000.00 |
| Dec 31, 2019 | 263,000.00 |
| Sep 30, 2019 | 303,000.00 |
| Dec 31, 2018 | 288,000.00 |